University of Bordeaux, Inserm, Bordeaux Population Health Research Centre, Epicene Team, UMR 1219, 33000, Bordeaux, France; Department of Palliative Medicine, CHU Bordeaux, 33000, Bordeaux, France.
University of Bordeaux, Inserm, Bordeaux Population Health Research Centre, Biostatistic Team, UMR 1219, 33000, Bordeaux, France.
Eur J Cancer. 2020 Sep;137:240-249. doi: 10.1016/j.ejca.2020.07.007. Epub 2020 Aug 14.
Patients with metastatic breast cancer (MBC) often require inpatient palliative care (IPC). However, mounting evidence suggests age-related disparities in palliative care delivery. This study aimed to assess the cumulative incidence function (CIF) of IPC delivery, as well as the influence of age.
The national ESME (Epidemio-Strategy-Medical-Economical)-MBC cohort includes consecutive MBC patients treated in 18 French Comprehensive Cancer Centres. ICD-10 palliative care coding was used for IPC identification.
Our analysis included 12,375 patients, 5093 (41.2%) of whom were aged 65 or over. The median follow-up was 41.5 months (95% confidence interval [CI], 40.5-42.5). The CIF of IPC was 10.3% (95% CI, 10.2-10.4) and 24.8% (95% CI, 24.7-24.8) at 2 and 8 years, respectively. At 2 years, among triple-negative patients, young patients (<65 yo) had a higher CIF of IPC than older patients after adjusting for cancer characteristics, centre and period (65+/<65: β = -0.05; 95% CI, -0.08 to -0.01). Among other tumour sub-types, older patients received short-term IPC more frequently than young patients (65+/<65: β = 0.02; 95% CI, 0.01 to 0.03). At 8 years, outside large centres, IPC was delivered less frequently to older patients adjusted to cancer characteristics and period (65+/<65: β = -0.03; 95% CI, -0.06 to -0.01).
We found a relatively low CIF of IPC and that age influenced IPC delivery. Young triple-negative and older non-triple-negative patients needed more short-term IPCs. Older patients diagnosed outside large centres received less long-term IPC. These findings highlight the need for a wider implementation of IPC facilities and for more age-specific interventions.
转移性乳腺癌(MBC)患者通常需要住院姑息治疗(IPC)。然而,越来越多的证据表明姑息治疗的提供存在与年龄相关的差异。本研究旨在评估 IPC 提供的累积发生率函数(CIF),以及年龄的影响。
国家 ESME(Epidemio-Strategy-Medical-Economical)-MBC 队列包括在 18 个法国综合癌症中心接受治疗的连续 MBC 患者。使用 ICD-10 姑息治疗编码来识别 IPC。
我们的分析包括 12375 名患者,其中 5093 名(41.2%)年龄在 65 岁或以上。中位随访时间为 41.5 个月(95%置信区间[CI],40.5-42.5)。IPC 的 CIF 分别为 2 年和 8 年时的 10.3%(95%CI,10.2-10.4)和 24.8%(95%CI,24.7-24.8)。在 2 年时,在三阴性患者中,年轻患者(<65 岁)在调整癌症特征、中心和时期后,IPC 的 CIF 高于老年患者(65+/<65:β=-0.05;95%CI,-0.08 至-0.01)。在其他肿瘤亚型中,老年患者比年轻患者更频繁地接受短期 IPC(65+/<65:β=0.02;95%CI,0.01 至 0.03)。在 8 年时,在大中心之外,调整癌症特征和时期后,IPC 向老年患者提供的频率较低(65+/<65:β=-0.03;95%CI,-0.06 至-0.01)。
我们发现 IPC 的 CIF 相对较低,并且年龄会影响 IPC 的提供。年轻的三阴性和年长的非三阴性患者需要更多的短期 IPC。在大中心外诊断的老年患者接受的长期 IPC 较少。这些发现强调了需要更广泛地实施 IPC 设施,并需要更多针对年龄的干预措施。